Heron Therapeutics Inc (HRTX)

Sep 06, 2026

10,550,750 Shares in Heron Therapeutics, Inc. $HRTX Bought by BlackRock Inc. - MarketBeat

Sep 06, 2026

Sep 03, 2026

Heron Therapeutics stock trades at penny level as biotech focuses on pain and oncology pipeline - AD HOC NEWS

Sep 03, 2026

Sep 02, 2026

AXD2 Forecast — Price Target — Prediction for 2027 - TradingView

Sep 02, 2026

Aug 31, 2026

Heron Therapeutics, Inc. (NASDAQ:HRTX) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat

Aug 31, 2026

Aug 26, 2026

Heron Therapeutics Stock Short Interest Rises to 31.36% - quiverquant.com

Aug 26, 2026

Aug 21, 2026

Tejara Capital Ltd Buys New Stake in Heron Therapeutics, Inc. $HRTX - MarketBeat

Aug 21, 2026

Aug 21, 2026

Why Did FULC, MVIS, HRTX Stocks Plunge To 52-Week Lows Today? - Stocktwits

Aug 21, 2026

Aug 20, 2026

Heron (HRTX) Results Review: EPS Comes in Below Forecast on the Day; Price Reaction: Shares Move 4.13% Down in Latest TradingEarnings Turnaround - vinanet.vn

Aug 20, 2026

Aug 19, 2026

Heron Therapeutics Earnings Call: Growth Meets New Risks - TipRanks

Aug 19, 2026

Aug 19, 2026

Heron (HRTX) Watch: Records a 4.65% Increase to $0.31 at the Close; Key Range: the Session Ends Within the Reported Technical Boundaries in the Available RecordIV Contraction - vinanet.vn

Aug 19, 2026

Aug 19, 2026

H.C. Wainwright Maintains Heron Therapeutics(HRTX.US) With Hold Rating - Moomoo

Aug 19, 2026

Aug 17, 2026

Weekly Recap: Guidance withdrawn over CINVANTI patent and HRTX Q2 revenue $37.7M - TradingView

Aug 17, 2026

Aug 13, 2026

HC Wainwright Has Pessimistic Outlook of HRTX Q3 Earnings - MarketBeat

Aug 13, 2026

Aug 12, 2026

HERON THERAPEUTICS INC : H.C. WAINWRIGHT CUTS TO NEUTRAL FROM BUY - webull.com

Aug 12, 2026

Aug 11, 2026

H.C. Wainwright Downgrades Heron Therapeutics(HRTX.US) to Hold Rating - Moomoo

Aug 11, 2026

Aug 11, 2026

Heron Therapeutics earnings missed by $0.02, revenue fell short of estimates - Investing.com Canada

Aug 11, 2026

Aug 10, 2026

Heron Therapeutics Inc (HRTX) (Q2 2026) Earnings Call Highlights: Revenue Growth Amid Strategic ... - finance.yahoo.com

Aug 10, 2026

Aug 10, 2026

Heron Therapeutics Q2 2026 Loss Widens 50.0% Beyond Estimates - AlphaStreet

Aug 10, 2026

Aug 10, 2026

Heron Therapeutics: Q2 Earnings Snapshot - AOL.com

Aug 10, 2026

Aug 10, 2026

Heron Therapeutics Releases Q2 2026 Financial Results - AlphaStreet

Aug 10, 2026

Aug 10, 2026

Heron Therapeutics Q2 2026 Earnings Call Transcript - MarketBeat

Aug 10, 2026

Aug 10, 2026

Heron Therapeutics Withdraws 2026 Guidance as CINVANTI Patent Risk and Strategic Review Cloud Outlook - Yahoo Finance

Aug 10, 2026

Aug 10, 2026

Earnings call transcript: Heron Therapeutics misses Q2 2026 revenue forecast By Investing.com - Investing.com Canada

Aug 10, 2026

Aug 10, 2026

Heron Therapeutics Q2 Earnings Call Highlights - MarketBeat

Aug 10, 2026

Aug 10, 2026

Heron Therapeutics (HRTX) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Aug 10, 2026

Aug 10, 2026

development in the article - Minichart

Aug 10, 2026

Aug 10, 2026

Heron Therapeutics (NASDAQ:HRTX) Issues Earnings Results - MarketBeat

Aug 10, 2026

Aug 10, 2026

HERON THERAPEUTICS INC HERON TH (0J4V.L) Q2 FY2026 earnings call transcript - Yahoo Finance

Aug 10, 2026

Aug 10, 2026

Heron Therapeutics Announces Second Quarter 2026 Financial Results - The Manila Times

Aug 10, 2026

Aug 10, 2026

Heron Therapeutics Q2 revenue rises on acute care growth, withdraws 2026 outlook - TradingView

Aug 10, 2026

Aug 10, 2026

Heron Therapeutics Q2 Revenue Rises To $37.7 Million - Quiver Quantitative

Aug 10, 2026

Aug 10, 2026

Heron Therapeutics reports Q2 2026 revenue $37.7M, withdraws 2026 guidance after patent ruling - TradingView

Aug 10, 2026

Aug 08, 2026

Wall Street Zen Upgrades Heron Therapeutics (NASDAQ:HRTX) to Sell - MarketBeat

Aug 08, 2026

Aug 07, 2026

HERON THERAPEUTICS Q2 2026 Earnings Preview: Recent $HRTX Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

Aug 07, 2026

Aug 07, 2026

Heron Therapeutics Inc expected to post earnings of 1 cent a shareEarnings Preview - TradingView

Aug 07, 2026

Aug 07, 2026

HRTX Q1 2026 Earnings: EPS Misses Estimates as Net Loss WidensEarnings Miss Streak - vinanet.vn

Aug 07, 2026

Aug 06, 2026

Heron Therapeutics, Inc. (NASDAQ:HRTX) Receives Average Recommendation of "Hold" from Analysts - MarketBeat

Aug 06, 2026

Aug 05, 2026

Heron Therapeutics (NASDAQ:HRTX) Upgraded to Hold at Zacks Research - MarketBeat

Aug 05, 2026

Aug 04, 2026

Earnings Preview: HRTX to Report Financial Results Pre-market on August 10 - Moomoo

Aug 04, 2026

Aug 03, 2026

HRTX Q2'26 Earnings: revenue estimate is 42.19M USD - TradingView

Aug 03, 2026

Aug 03, 2026

Heron Therapeutics (HRTX) Projected to Post Quarterly Earnings on Monday - MarketBeat

Aug 03, 2026

Aug 01, 2026

Heron Therapeutics, Inc. Revenue Breakdown – NASDAQ:HRTX - TradingView

Aug 01, 2026

Jul 31, 2026

HRTX Q1 2026 Earnings: Wider-than-Expected Loss Signals Ongoing Cost PressureEPS Estimate Trend - vinanet.vn

Jul 31, 2026

Jul 27, 2026

Heron Therapeutics Inc Revenue Breakdown – BX:AXD2 - TradingView

Jul 27, 2026

Jul 27, 2026

Heron Therapeutics Inc (HRTX) Institutional Confidence - TradingKey

Jul 27, 2026

Jul 27, 2026

Heron Therapeutics to Report Second Quarter 2026 Financial Results on August 10 - Quiver Quantitative

Jul 27, 2026

Jul 27, 2026

Heron Therapeutics to Report Second Quarter 2026 Financial Results on Monday, August 10, 2026 - The Manila Times

Jul 27, 2026

Jul 27, 2026

Orbimed Advisors LLC Makes New Investment in Heron Therapeutics, Inc. $HRTX - MarketBeat

Jul 27, 2026

Jul 27, 2026

Heron Therapeutics Inc (HRTX) Cash Flow - TradingKey

Jul 27, 2026

Jul 27, 2026

Heron Therapeutics Inc (HRTX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 27, 2026

Jul 25, 2026

Heron Therapeutics Inc (AXD2) Q4 2022 Earnings ReportResults, Call & Slides - TipRanks

Jul 25, 2026

Jul 25, 2026

Heron Therapeutics Inc (AXD2) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks

Jul 25, 2026

Jul 25, 2026

Heron Therapeutics Inc (HRTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 25, 2026

Jul 25, 2026

Heron Therapeutics Inc (HRTX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 25, 2026

Jul 25, 2026

HRTX|Heron Therapeutics Inc|Price:0.330|Chg%:+0.017 - TradingKey

Jul 25, 2026

Jul 25, 2026

HRTX|Heron Therapeutics Inc|Price:0.456|Chg%:-0.003 - TradingKey

Jul 25, 2026

Jul 24, 2026

Heron Therapeutics Inc (HRTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 24, 2026

Jul 23, 2026

VOO Stock Price TodayVanguard S&P 500 ETF News, Charts, Retail Sentiment - Stocktwits

Jul 23, 2026

Jul 22, 2026

Heron Therapeutics Inc (AXD2) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks

Jul 22, 2026

Jul 22, 2026

Heron Therapeutics Inc (AXD2) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks

Jul 22, 2026

Jul 22, 2026

Heron Therapeutics Inc (AXD2) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks

Jul 22, 2026

Jul 17, 2026

Heron Therapeutics Inc (HRTX) Q3 2023 Earnings ReportResults, Call & Slides - TipRanks

Jul 17, 2026